Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 9901-9950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06843226
A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease
N/ARecruiting
70,000 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor3 locations
NCT06580054
Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma
PHASE2Recruiting
22 participants
Started: Mar 5, 2025 · Completed: Mar 1, 2030
3 conditions1 sponsor1 location
NCT06637306
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
EARLY_PHASE1Recruiting
15 participants
Started: Mar 5, 2025 · Completed: Jun 1, 2027
2 conditions1 sponsor1 location
NCT06821295
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing Homelessness
PHASE2/PHASE3Recruiting
600 participants
Started: Mar 5, 2025 · Completed: Apr 30, 2029
2 conditions2 sponsors1 location
NCT06857708
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
NARecruiting
50 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06548230
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
PHASE1/PHASE2Recruiting
40 participants
Started: Mar 5, 2025 · Completed: Dec 1, 2029
2 conditions1 sponsor1 location
NCT06806033
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE2Recruiting
100 participants
Started: Mar 5, 2025 · Completed: Mar 30, 2029
1 condition1 sponsor48 locations
NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
PHASE1Recruiting
130 participants
Started: Mar 5, 2025 · Completed: Aug 31, 2029
5 conditions1 sponsor7 locations
NCT06816914
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial
PHASE2Recruiting
84 participants
Started: Mar 5, 2025 · Completed: Feb 5, 2028
1 condition8 sponsors9 locations
NCT06824987
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
PHASE2Recruiting
96 participants
Started: Mar 5, 2025 · Completed: Aug 30, 2027
1 condition1 sponsor77 locations
NCT06886867
Comparing Exergaming and Usual Care Physical Therapy in Nursing Home Residents
NARecruiting
52 participants
Started: Mar 5, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT06870500
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient
NARecruiting
50 participants
Started: Mar 5, 2025 · Completed: Mar 10, 2026
1 condition1 sponsor1 location
NCT06770010
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
NARecruiting
50 participants
Started: Mar 5, 2025 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT06774079
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
PHASE4Recruiting
24 participants
Started: Mar 5, 2025 · Completed: Mar 5, 2026
1 condition1 sponsor1 location
NCT06764641
PAN Alimentary Cancer Exhaled Breath Analysis
N/ARecruiting
8,000 participants
Started: Mar 5, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06822517
A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
PHASE1/PHASE2Recruiting
30 participants
Started: Mar 5, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor23 locations
NCT06660732
Rilonacept in Subjects With Cardiac Sarcoidosis
PHASE2Recruiting
60 participants
Started: Mar 5, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors2 locations
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
PHASE2Recruiting
60 participants
Started: Mar 5, 2025 · Completed: Oct 31, 2028
3 conditions4 sponsors1 location
NCT06495996
The Protrieve PROTECTOR Study
NARecruiting
60 participants
Started: Mar 5, 2025 · Completed: Mar 31, 2026
2 conditions1 sponsor15 locations
NCT06862375
Weight Loss Through Mayo Clinic Diet
NARecruiting
250 participants
Started: Mar 5, 2025 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT07210944
A Brain Network Study on the Treatment of Upper Limb Motor Dysfunction in Stroke Patients Using Scalp Acupuncture Combined With rTMS
NARecruiting
44 participants
Started: Mar 5, 2025 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06601140
Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Moderate Depressive Episode
NARecruiting
104 participants
Started: Mar 5, 2025 · Completed: Nov 4, 2025
1 condition7 sponsors7 locations
NCT06371976
Evaluation of the HPA Axis in Patients With Vasoplegic Syndrome After Cardiac Surgery
N/ARecruiting
200 participants
Started: Mar 5, 2025 · Completed: Mar 5, 2026
1 condition1 sponsor1 location
NCT07195383
GUSS-ICU Safe Nutrition Program After Extubation in ICU Patients
NARecruiting
82 participants
Started: Mar 5, 2025 · Completed: Jun 30, 2026
2 conditions1 sponsor2 locations
NCT06817668
Evaluating Tolerability of ePUHRT With Brachytherapy Boost
NARecruiting
31 participants
Started: Mar 5, 2025 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06710197
IL-1 Inhibition in Early TNBC
PHASE2Recruiting
50 participants
Started: Mar 5, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT06816875
Comparison of the User Experience of Four Nasal Aspirators in Infants
NARecruiting
28 participants
Started: Mar 5, 2025 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT06749964
An N-of-1 Trial of an Internet-delivered CBT Program Based on the Psychological Flexibility Model of Chronic Pain for Cancer-related Difficulties
NARecruiting
30 participants
Started: Mar 5, 2025 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT06423378
Bio-Integrative, Fiber-Reinforced Kneebar for Treating Subchondral Insufficiency of the Knee
PHASE2Recruiting
10 participants
Started: Mar 5, 2025 · Completed: Dec 5, 2026
1 condition1 sponsor1 location
NCT06848192
The Parkinson's Disease Case-Control Study
N/ARecruiting
40 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06784323
Tailored Anti-Inflammatory (A-I) Diet for Hispanics With Ulcerative Colitis (UC)
NARecruiting
122 participants
Started: Mar 5, 2025 · Completed: Sep 1, 2030
1 condition2 sponsors1 location
NCT06731335
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
PHASE2Recruiting
30 participants
Started: Mar 5, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06397417
Refractory Cardiac Arrest Treated On Field By ECMO
N/ARecruiting
840 participants
Started: Mar 5, 2025 · Completed: Mar 31, 2046
2 conditions2 sponsors1 location
NCT07071506
New Methods for Evaluating Preventive Migraine Treatment
NARecruiting
60 participants
Started: Mar 4, 2025 · Completed: Sep 30, 2028
4 conditions1 sponsor2 locations
NCT06960148
Dentinal Hypersensitivity Reduction Efficacy Study
PHASE3Recruiting
100 participants
Started: Mar 4, 2025 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06093893
Hypotensive Anesthesia for Orthognathic Surgery
PHASE4Recruiting
90 participants
Started: Mar 4, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06845943
A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes
EARLY_PHASE1Recruiting
48 participants
Started: Mar 4, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06541639
EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors
PHASE1Recruiting
78 participants
Started: Mar 4, 2025 · Completed: Jun 30, 2028
1 condition3 sponsors2 locations
NCT06926816
Universal Genetic Testing for Cancer Risk Reduction
NARecruiting
600 participants
Started: Mar 4, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07096154
Improving Emotional Wellbeing of University Students: Anxiety Management
NARecruiting
40 participants
Started: Mar 4, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06941298
Neural and Psychiatric Consequences of Cannabis Use in Adolescents
NARecruiting
280 participants
Started: Mar 4, 2025 · Completed: Jun 1, 2029
2 conditions3 sponsors2 locations
NCT06772181
A Digital Health Intervention to Improve Symptoms and Physical Activity During Breast Radiation
NARecruiting
40 participants
Started: Mar 4, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT04254419
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
PHASE1Recruiting
18 participants
Started: Mar 4, 2025 · Completed: Oct 31, 2031
1 condition1 sponsor1 location
NCT06767462
An Ophthalmic Safety Study in Patients With Breast Cancer
N/ARecruiting
160 participants
Started: Mar 4, 2025 · Completed: Jul 6, 2027
1 condition1 sponsor75 locations
NCT06404684
Psychological Treatment for Paraphilic Disorders
NARecruiting
14 participants
Started: Mar 4, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT07080489
Exploring the Role of the Prefrontal Cortex in Decision-Making
NARecruiting
444 participants
Started: Mar 4, 2025 · Completed: Oct 31, 2027
3 conditions2 sponsors1 location
NCT06840080
OEA and LipiSperse Metabolic Study
PHASE4Recruiting
40 participants
Started: Mar 4, 2025 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT06538285
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
PHASE2Recruiting
12 participants
Started: Mar 4, 2025 · Completed: Jun 30, 2026
1 condition4 sponsors1 location
NCT06828484
Allergenic Extract Standardized Cat Hair AP in an Allergic Rhinitis Model.
NARecruiting
20 participants
Started: Mar 4, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06603519
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
NARecruiting
30 participants
Started: Mar 4, 2025 · Completed: Feb 28, 2026
6 conditions2 sponsors1 location